A report by PTI says that Nepal’s drugs watchdog has asked Ramdev’s Patanjali Ayurveda to recall several Ayurvedic medicines. Ramdev’s Patanjali has risen like no other company after the formation of NDA government under Prime Minister Narendra Modi.
Yoga guru has been a huge supporter of Modi and the saffron camp and campaigned for the saffron party in major elections recently.
Reports suggest that Nepal’s medical watchdog has asked Patanjali to recall six drugs from Nepali market claiming that these were found to be of “substandard quality” following microbial tests.
Patanjali has manufacturing units in Nepal under the trademark Nepal Gramudhyog and imports majority of herbs in India from Himalayas of Nepal. According to CLSA and HSBC, Patanjali is the fastest growing FMCG company in India. It is valued at ₹30 billion (US$470 million) and some predict revenues of ₹5,000 crore (US$780 million) for the fiscal 2015–16. Ramdev baba has stated in his interview with CNN-News18 that profit from Patanjali Products goes to charity. Baba Ramdev established the Patanjali Ayurved Limited in 2006 along with Acharya Balkrishna with the objective of establishing science of Ayurveda in accordance and coordination with the latest technology and ancient wisdom.
Future Group which has tied up with Patanjali sells about ₹30 crore (US$4.7 million) worth of Patanjali products every month. Patanjali Food and Herbal Park at Haridwar is the main production facility operated by Patanjali Ayurved. The company has a production capacity of ₹350 billion (US$5.4 billion) and is in the process of expanding to a capacity of ₹600 billion (US$9.3 billion) through its new production units at several places, including Noida, Nagpur, and Indore. The company plans to establish further units in India and in Nepal.
A PTI report said that Nepal’s Department of Drug Administration, in a public notice, said six Ayurvedic medical products made by Divya Pharmacy in Uttarakhand, were found to be substandard during inspections at various outlets and tests on specimens. The medicines which failed the microbial tests are Patanjali’s Amla Churna, Divya Gashar Churna, Bahuchi Churna, Triphala Churna, Aswangandha and Adviya Churna, the notice said.
The batch of medicine which was inspected by the department are found to have contained pathogenic bacteria,” an official of the Department told PTI. The Nepalese drug authorities have urged the stakeholders not to sell or prescribe the use of these six medicines with immediate effect. A source at Patanjali Ayurveda Kendra in Kathmandu, the sole distributor of the products in Nepal, said the medicines have not been banned but restriction was imposed on the sale and use of certain batch of the medicines that failed lab test. The company officials have said that they will promptly recall products if asked to do so.